Hyderabad Telangana, India

Srinivas Pullela Venkata

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Hyderabad, IN (2015)
  • Bangalore Karnataka, IN (2015)

Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Srinivas Pullela Venkata: Innovator in Pharmaceutical Processes

Introduction

Srinivas Pullela Venkata is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug synthesis. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

His latest patents include "Processes for preparation of Everolimus and intermediates thereof." This patent discloses processes for synthesizing Everolimus by reacting Sirolimus (Rapamycin) under solvent-free conditions, utilizing appropriate side chain additions, one-pot conversion, and resin-mediated synthesis. Another significant patent is titled "Method of synthesizing a substantially monodispersed mixture of oligomers." This invention focuses on methods for synthesizing oligomeric compounds, particularly those comprising polyethylene glycol moieties. The methods provided in this patent offer improved synthesis conditions that are milder and more efficacious than conventional methods.

Career Highlights

Srinivas is currently associated with Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to contribute to the advancement of pharmaceutical technologies and processes.

Collaborations

He has collaborated with notable coworkers such as Ganesh Ekambaram and Kiran Kumar Kothakonda, further enhancing the innovative environment at Biocon Limited.

Conclusion

Srinivas Pullela Venkata's contributions to pharmaceutical processes through his patents reflect his dedication to innovation in the field. His work continues to influence the development of effective drug synthesis methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…